UAEM - Licensing and patenting practices of UK research institutions 2019-2020

Sarai Keestra made this Freedom of Information request to University of Leicester

Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

Response to this request is long overdue. By law, under all circumstances, University of Leicester should have responded by now (details). You can complain by requesting an internal review.

Dear University of Leicester,

We have previously sent FOI requests asking for information about the licensing practices of UK universities. This was concerning the time period 18th October 2018 to 18th October 2019. We are now looking to update the information for the following year, 19th October 2019 to 19th October 2020.

The updated request is listed below:
For the purpose of clarity, please adhere to the following definitions when answering these questions:

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online []

A patent grants an inventor the exclusive rights to his or her invention. A patent holder can stop other people from selling, manufacturing, producing, or using the invention for a certain period of time.
Source: Upcouncil, available online [
Licence: Permission for the licensee to use the intellectual property rights
Source: TaylorWessing, available online [

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’
Source: WHO, available online [

START FOI request:
Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the period 19th October 2019 to 19th October 2020 AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.
Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide a list of patents granted to your organization in the period 19th October 2019 to 19th October 2020, listed by patent family, indicating countries/regions in which the patent has been granted.

Q4. In the period 19th October 2019 to 19th October 2020, has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?

❏ Contributed sample clauses to the AUTM Global Health Toolkit
❏ Published an article, guidance, or other literature on access licensing practices
❏ Formally presented on access licensing practices at an academic or professional event, or at another university
❏ Informally shared or discussed access licensing practices with administrators at other universities
❏ Other
❏ None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the period 19th October 2019 to 19th October 2020 to improve access to the technologies they license in low-and middle-income settings?

END FOI request.
If you have any questions please do not hesitate to contact me by email.

Yours faithfully,

Sarai Keestra

Dear Sarai

I write to acknowledge receipt of your request, dated 10th November 2020, made under the provisions of the Freedom of Information Act 2000.

Please note the effective date of the request, i.e. date of receipt of your request by the University of Leicester for processing, is 10th November 2020 and that the latest date by which the University must respond under the terms of the Freedom of Information Act 2000 is 8th December 2020.

I will arrange for the information to which you are entitled under the Freedom of Information Act 2000 to be supplied to you as soon as reasonably possible, and in any event within the period set out by the Act.

Please note that due to the latest Covid 19 lockdown and with many staff working from home, it may take a little longer than normal for us to respond.

If you have any queries regarding your request, please do not hesitate to contact me.


Christine Taylor
Senior Information Assurance Officer

Legal and Information Assurance Services,
University of Leicester, University Road, Leicester, LE1 7RH, UK

Even though I may have sent this email to you during my working hours I do not expect you to read it or respond outside your own working hours.

During the COVID 19 Closure the IAS team are working from home and can be contacted by Email.
e: [email address]  

Follow us on Twitter or visit our Facebook page

Please note that the IAS team will be operating from [email address] when handling requests made under the Freedom of Information Act 2000. For all other correspondence, please continue to contact us through [email address].

show quoted sections